J.M. Arbour’s Amgen AMGN Stock Holding History

J.M. Arbour’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$225K	Sell	640 -180	-22%	-$64.2K	0.22%	111
2025 Q4	$268K	Buy	+820	New	+$260K	0.27%	91

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

J.M. Arbour's AMGN Position: Q1 2026 in Review

J.M. Arbour reduced its Amgen (AMGN) stake by 22% in Q1 2026, selling an estimated $64.2K and leaving 640 shares worth $225K. The position accounts for 0.22% of the portfolio, ranked #111.

J.M. Arbour first reported a position in AMGN in Q4 2025 and has held it in 2 quarters since. The position peaked at $268K in Q4 2025. 3,137 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

J.M. Arbour held 640 shares of Amgen worth $225K as of Q1 2026.
J.M. Arbour sold 180 Amgen shares in Q1 2026, an estimated $64.2K.
Amgen made up 0.22% of J.M. Arbour's portfolio in Q1 2026, its #111 holding.
J.M. Arbour first reported a position in Amgen in Q4 2025 and has held it in 2 quarters since.
J.M. Arbour's Amgen position peaked at $268K in Q4 2025.
3,137 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on J.M. Arbour's 13F filing for Q1 2026, filed 21 Apr 2026.